Fri, May 10, 2024

Jonathan Wolleben Maintained (ALT) at Buy with Decreased Target to $24 on, May 10th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-24-on-may-10th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jonathan Wolleben of JMP Securities, Maintained "Altimmune, Inc." (ALT) at Buy with Decreased Target from $25 to $24 on, May 10th, 2024.

Jonathan has made no other calls on ALT in the last 4 months.



There are 4 other peers that have a rating on ALT. Out of the 4 peers that are also analyzing ALT, 2 agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Seamus Fernandez of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, April 29th, 2024
  • Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024


These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $12 on, Monday, April 1st, 2024
  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024

Publication Contributing Sources